This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
Cytokeratin 5 Antibody, 6, clone D5/16B4
catalog :
MAB1620
quantity :
50 µg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
D5/16B4

The same clone is also sold as:
reactivity :
human, mouse
application :
western blot, immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section
citations: 20
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 2
Yamano S, Gi M, Tago Y, Doi K, Okada S, Hirayama Y, et al. Role of deltaNp63(pos)CD44v(pos) cells in the development of N-nitroso-tris-chloroethylurea-induced peripheral-type mouse lung squamous cell carcinomas. Cancer Sci. 2016;107:123-32 pubmed publisher
  • immunohistochemistry - paraffin section; human; 1:400
McCart Reed A, Kutasovic J, Vargas A, Jayanthan J, Al Murrani A, Reid L, et al. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas. J Pathol. 2016;238:489-94 pubmed publisher
  • immunohistochemistry; human; 1:400
Winczura P, Sosińska Mielcarek K, Duchnowska R, Badzio A, Lakomy J, Majewska H, et al. Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients. Pathol Oncol Res. 2015;21:1229-36 pubmed publisher
Somerville T, Xu Y, Miyabayashi K, Tiriac H, Cleary C, Maia Silva D, et al. TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma. Cell Rep. 2018;25:1741-1755.e7 pubmed publisher
Offenbacher S, Jiao Y, Kim S, Marchesan J, Moss K, Jing L, et al. GWAS for Interleukin-1β levels in gingival crevicular fluid identifies IL37 variants in periodontal inflammation. Nat Commun. 2018;9:3686 pubmed publisher
Jang W, Chen X, Flis D, Harris M, Schwob J. Label-retaining, quiescent globose basal cells are found in the olfactory epithelium. J Comp Neurol. 2014;522:731-49 pubmed publisher
Tago Y, Yamano S, Wei M, Kakehashi A, Kitano M, Fujioka M, et al. Novel medium-term carcinogenesis model for lung squamous cell carcinoma induced by N-nitroso-tris-chloroethylurea in mice. Cancer Sci. 2013;104:1560-6 pubmed publisher
Butler R, Spector M, Thomas D, MCDANIEL A, McHugh J. An immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma. Head Neck Pathol. 2014;8:133-40 pubmed publisher
Sosińska Mielcarek K, Duchnowska R, Winczura P, Badzio A, Majewska H, Lakomy J, et al. Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: the role of Rad51. Breast. 2013;22:1178-83 pubmed publisher
Senkus E, Szade J, Pieczyńska B, Zaczek A, Brozek I, Radecka B, et al. Are bilateral breast cancers different from breast cancers coexisting with ovarian cancer? An immunohistochemical analysis aimed at intrinsic tumor phenotype. Breast. 2013;22:425-30 pubmed publisher
Allende D, Dumot J, Yerian L. Esophageal squamous cell carcinoma arising after endoscopic ablation therapy of Barrett's esophagus with high-grade dysplasia. Report of a case. Dis Esophagus. 2013;26:314-8 pubmed publisher
Lott Limbach A, Hoschar A, Thompson L, Stelow E, Chute D. Middle ear adenomas stain for two cell populations and lack myoepithelial cell differentiation. Head Neck Pathol. 2012;6:345-53 pubmed publisher
De Silva Rudland S, Platt Higgins A, Winstanley J, Jones N, Barraclough R, West C, et al. Statistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers. Am J Pathol. 2011;179:1061-72 pubmed publisher
Holbrook E, Wu E, Curry W, Lin D, Schwob J. Immunohistochemical characterization of human olfactory tissue. Laryngoscope. 2011;121:1687-701 pubmed publisher
Bao L, Haque A, Jackson K, Hazari S, Moroz K, Jetly R, et al. Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model. Am J Pathol. 2011;178:838-52 pubmed publisher
Geyer F, Kushner Y, Lambros M, Natrajan R, Mackay A, Tamber N, et al. Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma. Histopathology. 2009;55:732-43 pubmed publisher
Long K, Hornick J. SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract. Hum Pathol. 2009;40:1768-73 pubmed publisher
Sohsman M, Yang H, Cassarino D. Sinonasal undifferentiated carcinoma metastatic to the skin. J Cutan Pathol. 2010;37:1241-4 pubmed publisher
Skala C, Petry I, Gebhard S, Hengstler J, Albrich S, Maltaris T, et al. Isolation of fibroblasts for coating of meshes for reconstructive surgery: differences between mesh types. Regen Med. 2009;4:197-204 pubmed publisher
Laczko I, Hudson D, Freeman A, Feneley M, Masters J. Comparison of the zones of the human prostate with the seminal vesicle: morphology, immunohistochemistry, and cell kinetics. Prostate. 2005;62:260-6 pubmed
product information
Catalog Number :
MAB1620
Subcategory :
Cell Structure
Product Name :
Anti-Cytokeratin 5 Antibody, 6, clone D5/16B4
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
P13647
Host Name :
Mouse
Antigen :
Cytokeratin 5
Clone :
D5/16B4
Conjugate :
Purified
Isotype :
IgG1
Product Description :
Anti-Cytokeratin 5 Antibody, 6, clone D5/16B4
Cross Reactivity :
Human;Mouse;Rat
Background :
The cytokeratins are a family of intermediate filaments found in almost all epithelial cells. They are divided into four subclasses depending on their patterns of reactivity and electrophoretic characteristics and are also arranged I a numbered series of 20 or more acoring to molecular weight and isoelectric point (Quinlan et al. 1985). Types 5 and 6 of cytokeratin (CK5/6) are in high frequency in mesothelial cells, as opposed to cells of adenocarcinoma. CK5/6 has been shown to be a reliable marker for mesothelioma and squamous cell carcinoma of the lung and Bowen's disease. It does not react with pulmonary adenocarcinoma.
ALT Names :
58 kDa cytokeratin;epidermolysis bullosa simplex;Dowling-Meara/Kobner/Weber-Cockayne types;keratin 5;keratin 5 (epidermolysis bullosa simplex,Dowling-Meara/Kobner/Weber-Cockayne types);keratin, type II cytoskeletal 5
Immunogen :
Purified cytokeratin 5 (Exp. Cell Res. (1986) 162:114; J. Invest. Dermatology (1987) 88:191).
Specificity :
Reacts with human cytokeratin 5 on immunoblots of cytoskeletal preparations of epidermis and non-cytokeratinizing epithelium (Abstract: European Symposium of the Biology of the Cytoskeleton, Helsinki, 18-21, 6, 89, 1989) and on tissue sections. Shows reactivity with cytokeratin 6 and weak reactivity with cytokeratin 4 on immunoblots. No cross-reactivity with cytokeratins 1, 7, 8, 10, 13, 14, 18 or 19. MAB1620 recognizes basal cells and a part of the stratum spinosum in the normal pavement epithelium. The antibody may be useful for distinction of low differentiated pavement epithelium carcinoma and adenocarcinoma. The antibody works on formalin fixed tissues.
Package Size :
50 µg
Uses :
Immunofluorescence;Immunohistochemistry (Paraffin);Western Blotting
Storage :
Stable for 6 months at 2-8°C in undiluted aliquots from date of receipt.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com
888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany

Hundreds of New Antibodies in the areas of:
  • • Cancer
  • • Nuclear Signaling
  • • Apoptosis
  • • Cardiovascular Disease
  • • Developmental Biology
  • • Metabolic Disease
  • • Neurodegenerative Disease
  • • Cell Biology
View all the new antibodies at www.emdmillipore.com.